A comparison of breast cancer risk factors, breast tumor characteristics, and p16 expression in DCIS and IDC cases revealed that low levels of p16 expression in DCIS cases was closely correlated with advanced age, later menarche, smaller tumor size, well-differentiated tumors, and low cell proliferation rates. Here, CDKN2A is linked to neoplasm.